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ABSTRACT
Some selected amino acids, in particular L-aspartic
acid (L-Asp) and L-histidine (L-His), can function
as leaving group during polymerase-catalyzed
incorporation of deoxyadenosine monophosphate
(dAMP) in DNA. Although L-Asp-dAMP and
L-His-dAMP bind, most probably, in a different way
in the active site of the enzyme, aspartic acid and
histidine can be considered as mimics of the
pyrophosphate moiety of deoxyadenosine triphos-
phate. L-Aspartic acid is more efficient than
D-aspartic acid as leaving group. Such P-N con-
jugates of amino acids and deoxynucleotides
provide a novel experimental ground for diversifying
nucleic acid metabolism in the field of synthetic
biology.
INTRODUCTION
DNA and RNA molecules naturally occurring in living
cells derive from nucleoside triphosphates, through an
iterative catalytic process condensing the nucleoside
50-phosphate moiety of these activated substrates to the
30-hydroxyl moiety of the elongating strand and releasing
pyrophosphate. A crucial aspect of this polymerization
process is that the pyrophosphate leaving group under-
goes hydrolysis under the action of pyrophosphatase, the
essential enzyme in charge of the irreversibility of
macromolecular biosynthesis (1). The energetics of protein
synthesis is also based on the release and subsequent
destruction of pyrophosphate through the transient
formation of amino acyladenylates by amino acyl-tRNA
synthetases (2). As an anhydride made up of two identical
phosphoryl moieties, pyrophosphate is endowed with a
compositional simplicity that provides the basis of
straightforward recycling processes for reconstituting the
pools of RNA and DNA precursors through P-O bond
rearrangements catalyzed by nucleotide kinases and
nucleoside diphosphate kinase (1). Altogether, cells have
evolved an eﬃcient network of enzymatic phospho-
transfers so as to reload phosphoanhydride bonds in
nucleotides using the potential energy of activated
intermediates in metabolism, e.g. phosphoenolpyruvate,
or using the chemo-osmotic potential of the cell mem-
brane proton gradient (2). This coupling between energy
storage and nucleic acid polymerization through phos-
phoanhydride formation and pyrophosphate release lies at
the core of cells chemical, energetic and genetic design. If,
for synthetic biology purposes, one attempted to diversify
enzymatic polymerization of nucleic acids in vivo by
condensing an additional category of activated nucleotides
bearing no pyrophosphate leaving group, the design of
such precursors would have to integrate features similar
to those embodied in the economy and simplicity of
phosphoanhydride metabolism. As a ﬁrst step toward
in vivo experiments along these lines, we set out to explore
in vitro metabolic prototypes of activated DNA precursors
such that: (i) they would serve as substrate for a DNA
polymerase; (ii) their consumption in DNA biosynthesis
would release as leaving group a metabolite common in
cells; (iii) the leaving group could be actively degraded or
recycled so as to enforce irreversibility of polymerization
and (iv) the leaving group could facilitate uptake of
activated DNA precursors through cell membranes.
Few successful attempts have been reported in the
literature to substitute functionally the pyrophosphate
leaving group of nucleoside triphosphates in nucleic acid
polymerization. Phosphorimidazolides and their 2-methyl
derivatives have been the topic of a systematic investiga-
tion of non-enzymatic polymerization of canonical and
non-canonical nucleotides in prebiotic studies (3).
Systematic substitution at the beta and gamma positions
of deoxynucleoside triphosphates has been studied by
Krayevsky and collaborators (4). Remarkably, dTTP
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gamma position of dNTPs were shown to undergo
polymerization catalyzed by HIV reverse transcriptase
and other viral and cellular DNA polymerases (5). More
recently, deoxynucleoside triphosphate analogues with a
P-C-P distal bridge replacing the P-O-P phosphoanhy-
dride have also been demonstrated to undergo condensa-
tion by DNA polymerase beta (6). Among conceivable
P-O, P-S, P-C and P-N conjugates of deoxynucleoside
monophosphates with physiological metabolites, phos-
phoramidate conjugates with amino acids (alias dNAP)
seemed particularly worthy of interest because their
structure lends itself to activation by the catalytic
Mg
2+ of DNA polymerases, much as deoxynucleoside
triphosphates (7). Their condensation by polymerases is
designed to release common amino acids, which can be
recycled or destroyed in subsequent metabolic steps.
In addition, they oﬀer an easy synthetic access and a
high enough stability toward spontaneous hydrolysis
under physiological conditions (378C, pH=7.5).
The second aim of this research project is to bypass the
kinase pathway for intracellular activation of modiﬁed
nucleosides. Nucleoside reverse transcriptase inhibitors
(NRTI) are designed to be recognized as substrates for RT
and incorporated into a growing strand for further
termination of chain elongation (8). Inhibition of reverse
transcriptase activity and chain termination by NRTI’s is
achieved by introduction of structural modiﬁcations in the
sugar moiety. These RT inhibitors are usually adminis-
tered as biologically inactive free nucleosides or nucleoside
phosphonates, or as nucleoside monophosphate/phospho-
nate prodrugs where the phosphate moiety is masked with
a lipophilic group (9). In the case of nucleoside adminis-
tration, three steps of kinase-mediated activation are
needed to generate the triphosphate in the cell. In the
prodrug concept, nucleoside 50-monophosphate kinase
and nucleoside 50-diphosphate kinase activities are needed
to provide the biological active congener (10). The
eﬃciency of these enzymatic phosphorylation reactions
depends on the substrate speciﬁcity of the diﬀerent
kinases. A nucleotide analogue that would not depend
on activation by nucleoside/nucleotide kinases whilst
serving as a natural substrate mimic, would be of great
interest.
Here, we present a series of amino acids phosphor-
amidate analogues in which a natural L-amino acid moiety
is linked through a P-N bond to 20-deoxyadenosine
50-O-monophosphate (Figure 1) and which might serve
as potential leaving group in a nucleotidyl transfer
reaction. Especially, the 50-aspartyl-phosphoramidate
and the 50-histidyl-phosphoramidate can mimic a natural
triphosphate moiety quite eﬀectively for the incorporation
of 20-deoxyadenosine into a growing DNA strand by HIV
RT and Therminator DNA polymerase. As demonstrated
by modelling studies, the amino acid moiety of this
deoxynucleotide analogue provides structural and electro-
static features essential for salt formation and/or metal
coordination and assembly of the catalytic residues in the
polymerase active site. In this respect, this study might
contribute to a better understanding of the mechanism of
biological polymerization reactions.
RESULTS
Synthesis of aminoacid phosphoramidates
The synthesis of methyl ester amino acid phosphorami-
date nucleotides analogues was accomplished according to
the method described by Wagner and colleagues starting
from nucleoside monophosphate (11). The details of the
synthesis of the compounds used in the study have been
described in a preliminary communication of this work
(7). L-amino acids were used for synthesis of the ﬁrst series
of phosphoramidate analogues. The deprotection of the
amino acid moiety was carried out with 0.4M sodium
hydroxide in methanol-water solution. The series of
phosphoramidate analogues coupled to a variety of
natural L-amino acids, synthesized for the study, is
shown in Figure 1.
Single nucleotide incorporation by HIV RT
HIV reverse transcriptase is involved in copying of the
HIV genome and uses deoxynucleotides as substrates.
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Figure 1. Structure of L-Amino Acid Phosphoramidates used in this study.
Nucleic Acids Research, 2007, Vol. 35, No. 15 5061HIV RT is an error-prone polymerase and has high
mutation rate (12). The essential role of the HIV RT in
viral replication and its ﬂexibility and tolerance toward
modiﬁed nucleotides renders this enzyme a primary target
in treatment of HIV infection. In the presented study, the
ability of HIV RT to incorporate a series of amino acid
phosphoramidatenucleotideanalogueswasinvestigatedby
the gel-based single nucleotide incorporation assay (13,14).
Among amino acid phosphoramidate nucleotides (1–8)
remarkable results were observed with Asp-dAMP (1)
(Figure 2).
This phosphoramidate analogue was recognized by HIV
RT and eﬃciently incorporated into a growing primer
strand resulting in 90% conversion to an (n+1) strand in
60min (500mM nucleotide concentration). At the same
conditions, incorporation of His-dAMP(6), Gly-dAMP (3)
and Pro-dAMP (7) were 1.5-, 6.5-, and 3.7-fold less
eﬃcient, respectively. Eﬃcient incorporation of Asp-
dAMP (24.1%) was also observed when the substrate
concentration was decreased 10-fold. However, signiﬁ-
cantlylesserincorporationofaminoacidphosphoramidate
was detected for nucleotides coupled to non-polar, hydro-
phobic amino acids. Ala-dAMP and Tyr-dAMP behaved
as poor substrates leading to merely 7- and 10-fold
reduction in primer extension, respectively (Figure 3).
Interestingly, no incorporation occurred when respec-
tive methyl ester derivatives of 1–8 (dimethylester for 1
and 2 as also the carboxylic acid function in the side chain
is methylated) were used as substrates in the polymerase
reaction (Figure 3, Panel II). An unexpected result was
observed with Glu-dAMP analogue (2) that also acted
very poorly as an HIV RT substrate. These observations
suggest that recognition and incorporation of amino acids
(AA) dAMPs is a very speciﬁc process and is likely to be
dictated by the chemical structure and electrostatics of the
amino acid moiety.
Since it is known that polymerases have tendency to
incorporate dAMP in a non-template manner, we
investigated whether the former observations were due
to a true base-pair extension. A control experiment with a
mismatch sequence (A against A) was carried out
(Figure 3, Panel III). As expected, Asp-dAMP (1) was
not incorporated at all into the growing primer strand.
After 2h of the polymerase reaction at 500mM substrate
concentration 0% conversion was observed. The same
results were observed when the substrate concentration
was increased to 1mM.
Single nucleotide incorporation byTherminator
DNA polymerase
Another polymerase enzyme that demonstrates similar
trends in recognition and utilization of AA-dAMPs is the
thermostable Therminator DNA polymerase, a variant of
(98N 7) Thermococcus species DNA polymerase. This
enzyme demonstrated eﬀective recognition and incorpora-
tion of a number of nucleotides bearing unnatural
nucleobase and sugar moieties (15–20). Likewise, probing
of AA-dAMP incorporation directed by Therminator
DNA polymerase revealed property of analogues 1, 3 and
6 to act eﬀectively as alternative substrates in the DNA
polymerization reaction (Figures 4 and 5).
Yet again, the best results were obtained with Asp-
dAMP, which led to 25.2% primer extension over 60min
at 500mM nucleotide concentration. At the same condi-
tions, similar results were obtained for Gly-dAMP and
His-dAMP (26 and 25.4% primer extension, respectively).
In the case of Glu-dAMP and methyl protected
AA-dAMPs, Therminator DNA polymerase displays
selectivity analogous to HIV reverse transcriptase and
fails to direct incorporation of those phosphoramidate
analogues (Figure 5).
Single nucleotide incorporation byother DNA polymerases
The remarkable property of Asp-dAMP encouraged
further investigation and testing 1 as a substrate for
other DNA polymerases. However, in the case of Taq,
Vent (exo
 ), and KF (exo
 ) DNA polymerases, recogni-
tion and incorporation eﬃciency were signiﬁcantly less
appealing. Incorporation and primer extension were
observed only in the case of KF (exo
 ) DNA pol
demonstrating 32.5% conversion of the primer strand in
60min. This is in contrast to Taq and Vent (exo
 ) DNA
polymerases that failed to insert 1 into a growing primer
strand. The diversity in incorporation selectivity that are
observed among the polymerases [Therminator, Taq, Vent
(exo
 ), KF (exo
 ) and HIV reverse transcriptase] could
indicate the diﬀerences in the active site ﬂexibility and
tolerance to the triphosphate modiﬁcations (Figure 6).
Although no data from human polymerases are yet
available, the selectivity for HIV-RT points to the
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Primer (P1)     5′-33P-CAG GAA ACA GCT ATG AC-3′
Template(T1)       3′-GTC  CTT  TGT CGA TAC TG TCC CC-5′
        
17mer 
+1
1 mM 500 µM 200 µM 100 µM dATP, 50 µM
1 mM
Asp-dAMP (1) dTTP
+1
500 µM 200 µM 100 µM dATP, 50 µM
Primer (P1)     5′-33P-CAG GAA ACA GCT ATG AC-3′
Template (T4)       3′-GTC  CTT  TGT CGA TAC TG ACT GAA AAA-5′
Figure 2. Panel I: incorporation of Asp-dAMP (1) by HIV RT. Panel
II: incorporation of dimethyl ester Asp-dAMP (1a) by HIV RT. Panel
III: control experiment for Asp-dAMP (1). Conditions. Panels I and II:
primer (P1) was 50-labelled with
33P followed by annealing to a
template T1; 125nM primer/template (P1/T1), [HIV RT]=0.03U/ml,
time intervals: 5, 15, 30, 60, 90 and 120min. Panel III: primer (P1) was
50-labelled with
33P followed by annealing to a template T4; 125nM
primer/template (P1/T4), [L-Asp-dAMP]=500mM, [dTTP]=10mM,
[HIV RT]=0.03U/mL, time intervals: 5, 15, 30, 60, 90 and 120min.
5062 Nucleic Acids Research, 2007, Vol. 35, No. 15potential of this approach for the design of direct reverse
transcriptase inhibitors as potential anti-HIV agents.
Primer extension by HIV RT
The further investigation of Asp-dAMP recognition by the
reverse transcriptase focused on ability of HIV RT to
direct template dependent incorporation of more than one
phosphoramidate nucleotides. For this purpose, template
T3 containing a string of three thymidine nucleobases
ﬂanked with cytidine nucleobases at the 30 end and the
template T7 that has an overhang of seven thymidine
residues were used. Ability to HIV RT to synthesize a
DNA sequence using phosphoramidate nucleotides as
substrates was tested among Asp-dAMP, His-dAMP,
Gly-dAMP and Pro-dAMP.
Among this series of phosphoramidate nucleotide, the
most encouraging results using T3 template were observed
with Asp-dAMP and His-dAMP which were used by HIV
RT to extend a primer with three adenine nucleobases
(n+3 product). The results of these gel electrophoresis
experiments are described in the preliminary communica-
tion (7).
However, after 60min of the polymerase reaction the
(n+2) product predominates over the (n+3) product
(56.3% versus, 5.2% for Asp-dAMP and 67.1% versus
13.5%). Interestingly, eﬃciency of DNA synthesis with
His-dAMP at 500 mM substrate concentration is similar or
better to that when Asp-dAMP serves as the substrate
(67.1% versus 56.2%, respectively, for the synthesis of the
(n+2) primer). This is in contrast to the single nucleotide
incorporation results that indicate that His-dAMP is less
good than Asp-dAMP as a substrate for HIV RT
(Figure 7). Eﬃciency of chain elongation and single
nucleotide incorporation is dependent on the structure
of the ‘leaving group’.
II
  +1
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17mer
17mer
1 mM
1 mM 500 µM 200 µM dATP, 50 µM
500 µM 200 µM 100 µM dATP, 50 µM
17mer
17mer
Figure 4. Panel I: incorporation of Asp-dAMP (1) by Therminator
DNA pol. Panel II: incorporation of dimethyl ester Asp-dAMP by
Therminator. Reaction conditions: primer (P1) was 50-labelled with
33P
followed by annealing to a template T1; 125nM primer/template
(P1/T1), [Therminator]=0.03U/ml, [primer]=0.125mM, time inter-
vals: 5, 15, 30, 60, 90 and 120min.
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Figure 3. Eﬃciency of phosphoramidate incorporation by HIV RT.
Nucleic Acids Research, 2007, Vol. 35, No. 15 5063In the case of the T5 template with the overhang of
seven thymidine nucleobases, HIV RT indeed generates
(n+6) and (n+7) products at a very little extent while
the (n+2) and (n+3) products are prevalent (Figure 8).
The obvious stalling of the HIV RT polymerase after
incorporation of two adenine nucleobases might indicate
substrate inhibition or a template sequence eﬀect.
The primer strand extension for 1h with 500mM of Gly-
dAMP or Pro-dAMP takes place with low eﬃciency and
does not result in the formation of the full-length
extension products.
Primer extension by Therminator DNA polymerase
The Therminator DNA pol mediated addition of amino
acid phosphoramidate nucleotides instead of natural
dNTPs at the 30 terminal end was investigated for several
AA-dAMPs. Similarly, to the case of HIV RT, the best
results were observed with Asp dAMP phosphoramidate,
which was successfully incorporated across from a string
of thymidine residues (T3 template) to provide an (n+3)
product (Figure 9).
However, when His-dAMP and Gly-dAMP were
used as substrates for Therminator DNA polymerase,
the primer extension took place with signiﬁcantly
lesser eﬃciency (13.6 and 18.1% of primer extension,
respectively) with the (n+1) product being predominant
and halted after addition of 2nt phosphoramidate
residues (Figure 10). The primer extension with
Pro-dAMP was very ineﬀective and resulted only
in addition of 1nt phosphoramidate residue at the
primer’s end.
It is interesting to note that in the case of the
T7 template with the overhang of seven thymidine
residues the predominant product of the primer exten-
sion was the (n+2) oligonucleotide. Nonetheless,
Therminator DNA polymerase was able to carry out
the extension of the T7 primer with Asp-dAMP
phosphoramidate and incorporate up to ﬁve adenine
residues.
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1 mM
1 mM 500 µM 200 µM 100 µM
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500 µM 200 µM 100 µM dATP, 50 µM
dATP, 50 µM
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Figure 6. Panel I: incorporation of Asp-dAMP (1) by Taq DNA
polymerase. Panel II: incorporation of Asp-dAMP (1) by Vent (exo
 )
DNA polymerase. Panel III: Incorporation of Asp-dAMP (1) by
Klenow Fragment (KF) (exo
 ) DNA polymerase. Reaction conditions:
primer (P1) was 50-labelled with
33P followed by annealing to a
template T1; 125nM primer/template (P1/T3), [Taq]=0.005U/ml,
[Vent]=0.005U/ml, [KF]=0.05U/ml; time points: 5, 15, 30, 60, 90
and 120min.
5064 Nucleic Acids Research, 2007, Vol. 35, No. 15Stereoselectivity of reverse transcriptase forthe amino
acidleaving groupand chain termination using an antiviral
nucleoside
In order to evaluate the inﬂuence of chirality of the
amino acid to function as a leaving group during the
incorporation reaction, we have compared D-Asp-dAMP
and L-Asp-dAMP as substrate for RT using template T1
and primer P1.
From the gel electrophoresis experiments it is clear that
the natural L-Asp-dAMP is a better substrate for RT than
D-Asp-dAMP (Figure 11). The stereoselectivity of the
reaction further support the idea that appropriate binding
and coordinating of the amino acid in the active site of the
enzyme is needed, in order to function as substrate.
From the point of view of applicability in the antiviral
ﬁeld, we have evaluated the potential of L-Asp-PMEA
(PhosphonoMethoxyEthylAdenine) to function as chain
terminator in the RT assay. PMEA is a potent anti-HIV
agent with a phosphonate moiety instead of a phosphate
group and lacking a free hydroxyl in the nucleoside
moiety, so that chain elongation is not possible (21). The
incorporation of PMEA using L-Asp as leaving group is
demonstrated in Figure 12, although high concentration
of the substrate is needed (100mM). It can be concluded
that L-Asp-PMEA is a substrate for RT and incorporation
of PMEA leads to chain termination. This experiment
demonstrates the potential of the approach to use
modiﬁed nucleosides having an alternative leaving group
as potential anti-HIV agents.
Molecular modelling of L-Asp-dAMP and L-His-dAMP in
theactive site ofHIV-RT
With the L-Asp-dAMP and L-His-dAMP molecules bound
to reverse transcriptase, stable molecular dynamics (MD)
trajectories were obtained.
In the L-Asp-dAMP complex (Figure 13b), the 2 Mg
2+
ions are comparable in position to their situation in the
original TTP complex (Figure 13a). They are tightly
bound to both COO
  groups of the L-Asp-dAMP
(mimicking the second and third phosphate groups),
the phosphoramidite group and to three Asp groups in
the enzyme: Asp110A and Asp185A which are widely
conserved in the polymerases and Asp186A (22,23).
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Primer (P1)     5′-33P-CAG GAA ACA GCT ATG AC-3′
Template(T7)       3′-GTC  CTT  TGT CGA TAC TG TTT TTTTC-5′
Asp-dAMP His-dAMP Gly-dAMP Pro-dAMP dATP BLANK
+7
+3
+6
Figure 8. Primer extension with amino acid phosphoramidates by HIV
RT. Reaction conditions: primer (P1) was 50-labelled with
33P followed
by annealing to a template T5; 125nM primer/template (P1/T5),
[AA-dAMP]=500mM; [dATP]=50mM; [HIV RT]=0.03U/ml; time
points: 5, 15, 30, 60, 90 and 120min. Blank: 125nM primer/template
(P1/T5), [HIV RT]=0.03U/ml, no nucleotide substrate.
Nucleic Acids Research, 2007, Vol. 35, No. 15 5065In the original X-ray structure, Asp186A is not involved
in an ionic bond with one of the Mg
2+ ions. In the
L-His-dAMP complex MD simulation reveals that the
L-His-dAMP binds in a diﬀerent manner (Figure 14).
The Mg
2+ ions shift during the simulation, i.e. Mg601A
moves 3.44A ˚ to Asp186A, while Mg600A moves 2.51A ˚ in
the direction of Asp185A. There is an ionic bond from one
phosphate oxygen to Mg
2+, and the coordination of the
Mg
2+ ions to three Asp residues is still present. The amino
acid COO
  of L-His-dAMP however is involved in a
salt bridge with Lys65A. The neutral His group of
L-His-dAMP is in an orientation facilitating a cationic-
aromatic interaction with one of the Mg
2+ ions (24).
Only a few dAMP residues are incorporated into the
primer, when feeding the enzyme with L-Asp-dAMP.
An explanation could be that the leaving group is bound
too tight to the enzyme so that it stays in the enzyme,
becoming an obstruction for new entering residues.
When mutating the L-Asp-dAMP into L-Glu-dAMP, this
glutamine side chain is too far from the Mg
2+ ions to
interact. Although the L-Glu-dAMP molecule ﬁts into the
NTP binding pocket (model not shown), no conclusion on
why this molecule is not incorporated in the chain can be
drawn based on that model.
Figures 13 and 14 are generated using Bobscript,
Molscript and Raster3d (25–27).
Stability of L-Asp-dAMP
In order to evaluate whether the low incorporation level
using some thermostable polymerases is not due to the
instability of the compound at higher temperature, we
have determined the chemical stability of dNAP in
diﬀerent conditions. The stability of L-Asp-dAMP was
investigated using 1D
31P NMR spectra. Within a pH
range of 6–8 and at a temperature of 258C no degradation
could be observed after a period of 2 days. At pH 7 and
Asp-dAMP His-dAMP Gly-dAMP Pro-dAMP dATP BLANK
+4
+3
17 mer
Figure 9. Primer extension with amino acid phosphoramidates by Therminator DNA polymerase. Reactions conditions: primer (P1) was 50-labelled
with
33P followed by annealing to a template T3; 125nM primer/template (P1/T3), [AA-dAMP]=500mM; [dATP]=50mM;
[Therminator]=8 10
 4U/ml; time points: 5, 15, 30, 60, 90 and 120min. Blank: 125nM primer/template (P1/T3), [Therminator]=8 10
 4U/ml,
no nucleotide substrate.
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5066 Nucleic Acids Research, 2007, Vol. 35, No. 158.8, at a temperature of 708C, the product degraded
following ﬁrst order reaction kinetics with a half life of
3.3h kdegr=and 2.8h, respectively.
DISCUSSION
A considerable amount of work has been done in the last
two decades exploring DNA polymerase mechanisms and
the factors involved in nucleotide recognition and poly-
merase ﬁdelity (28–31). Importantly, these studies have
provided extremely valuable information for rational
design of anti-viral, anti-cancer compounds as well as
nucleoside probes for various biotechnological applica-
tions (32–35). The presented study, hence, demonstrates
the successful and eﬃcient use of the amino acid moiety
linked to the a phosphate via a (P-N) phosphoramidate
bond as a diphosphate (pyrophosphate) group mimic.
This study revealed that the most remarkable recogni-
tion and nucleotide analogue incorporation was achieved
with 20-deoxyadenosine-50-aspartyl phosphoramidate
nucleotide analogue. Gel-based polymerase assay shows
that this analogue is successfully inserted into a growing
DNA strand by HIV Reverse Transcriptase and
Therminator DNA polymerase and that this incorpora-
tion is selective. It was also demonstrated that HIV RT
is capable of incorporation of 2–3 consecutive residues
of 1 in template-directed DNA synthesis. Likewise,
Therminator DNA polymerase also eﬃciently extends a
DNA primer by several nucleobases using the modiﬁed
substrate. Notably, in the case of HIV RT, the observed
stalling and termination of the DNA synthesis after
incorporation of two Asp-dAMP residues could possibly
indicate enzyme inhibition by either a competitive or a
non-competitive mechanism. Incorporation of the mod-
iﬁed substrate and the primer extension were observed
with His-dAMP analogue. Although His-dAMP was
inserted at a lesser extent than Asp-dAMP, primer
extension was comparable to the extension with 1 and
also resulted in a noticeable stalling at the +2 position.
Thus, it would be of a great interest to explore the causes
of the stalling and possible modes of substrate inhibition.
The kinetic analysis of Asp-dAMP incorporation shows
that the speciﬁcity for incorporation of this modiﬁed
substrate by HIV reverse transcriptase is  1300-fold lower
than that for the natural substrate (dATP) (7). The
signiﬁcantly higher Km value for the amino acid phos-
phoramidate analogue than for the natural substrate,
suggests that the phosphoramidate substrate dissociates
from the active site more readily and faster. Thus, high Km
value for Asp-dAMP implies weak binding to the
polymerase active site. However, the measured Vmax is
only 3-fold lower than this for the natural substrate
suggesting fast and eﬃcient nucleophilic displacement of
amino acid moiety once the amino acid phosphoramidate
substrate is bound at the active site and formation of a
phosphodiester bond. Therefore, it might be feasible to
design an amino acid phosphoramidate analogue with
higher aﬃnity for the polymerase active site while
retaining structural features responsible for eﬃcient
recognition and nucleotidyl transfer.
To be useful in biological experiments, it is important
that the amino acids-dAMP analogues are chemically and
enzymatically stable. The enzymatic stability has not been
evaluated, yet. However, the compounds have been
proven to be stable in water between pH 6 and pH 8 for
at least 2 days, their half life at pH 7 and pH 8.8at 708Ci s
3.3 and 2.8h, respectively. These stability studies have
been performed using NMR spectrometry to follow the
potential degradation reactions (data not shown). It is
expected that the phosphoramidate bond will become
unstable at a pH lower than 5. Exploration of the
substrate properties among a series of nucleotide phos-
phoramidates coupled to a wide spectrum of natural
amino acids revealed several important structural and
electrostatic features involved in triphosphate moiety
binding, recognition and nucleotidyl transfer. Numerous
structural studies indicate that the binding of the nucleo-
side triphosphate at the polymerase active site results in
coordination of at least two catalytically essential metals
(Mg
2+) (36–40). Furthermore, several catalytic, highly
conserved amino acid residues are also involved in
chelation of metal ions and proper positioning of the
triphosphate moiety for an ‘in-line’ nucleophilic attack at
the a phosphorus. It was suggested previously that initial
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Nucleic Acids Research, 2007, Vol. 35, No. 15 5067recognition of an incoming dNTP occurs through the
binding of the triphosphate moiety (38). Structural and
genetic analysis of a number of DNA polymerases and
reverse transcriptase indicates that amino acid residues
involved in the triphosphate binding are highly conserved
(36,38,39). In the case of HIV RT, binding of the incoming
dNTP is coordinated by Arg72 and Lys65 that make
interactions with the a- and g-phosphates, respectively
(Figure 13a) (39). This dNTP is also accompanied by 2
Mg
2+ ions, which are bound to the phosphates of the
nucleotide and to the two residues Asp185 and Asp110
(Figure 13a) (22,23).
Importantly, studies have shown that the binding of the
incoming dNTP and catalytic metal ions is responsible for
further rearrangements of the catalytic amino acid
residues as well as the relocation of the 30 primer terminus
in a position for the eﬀective nucleotidyl transfer (39).
Therefore, a proper geometric and spatial arrangement of
all reacting residues and atoms are essential for the
formation of the productive tertiary complex (36,37,40).
Eﬃcient incorporation of 1 might imply that the aspartyl
amino acid eﬀectively replaces the b and g phosphate
groups, likely. It can also be suggested that aspartate
moiety acts as a leaving group and mimics of a pyropho-
sphate group. Another example of activated nucleotide
and a use of a good leaving group is phosphorimidazolide
nucleotides, in which the a-phosphorus atom is activated
by imidazolide or methyl imidazolide moieties. Such
phosphoimidazolides deoxy- and ribonucleotides were
described as eﬃcient substrates for non-enzymatic tem-
plated and non-templated oligomerization (41–43).
Furthermore, the presented study clearly demonstrates
the requirement for the presence of the negative charge
and electrostatic interactions for eﬃcient binding of an
incoming nucleotide. This is evident from the study with
the aspartyl phosphoramidate (1) and bis-methoxy aspar-
tyl phosphoramidate (1a) where the protection of a
carboxylate groups brings drastic changes in ability of
HIV RT or Therminator DNA pol to recognize and
incorporate these two modiﬁed substrates. Although
aspartyl phosphoramidate nucleotide behaves as a good
nucleotide triphosphate analogue and substrate for HIV
RT and Therminator DNA polymerase, its methyl
protected derivative does not support DNA synthesis at
all. Comparison among the series of synthesized amino
acid phosphoramidates demonstrates that Asp-dAMP,
which possesses an extra negative charge, displays super-
ior properties as a polymerase substrate. The lower
eﬃciency of DNA synthesis using L-Asp-dAMP
(when compared with dATP) may also be attributed
to these electrostatic eﬀects (three negative charges for
L-Asp-dAMP versus four negative charges for dATP,
respectively), and the suggestion that the incoming dATP
brings 1 Mg
2+ in the active site, while the pyrophosphate
leaving group takes 1 Mg
2+ with it (44). Unexpectedly,
Glu-dAMP analogue that also possesses an extra negative
charge failed to serve as a substrate for both HIV RT and
Therminator DNA polymerase. A possible explanation
Figure 13. (a) X-ray structure of the RT dNTP pocket with bound Thymidine triphosphate (TTP). The primer strand is visualized by a green ribbon,
the template strand has a blue ribbon. The stabilizing interactions of the TTP within the complex are shown: hydrogen bond distances between the
bases are indicated in A ˚ . The ligation of the 2 Mg
2+ ions to the complex is also visualized by dashes and distances in A ˚ .( b) Average structure of
L-Asp-AMP in the RT dNTP pocket.
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a longer amino acid side chain (an extra methylene group)
as compare to the Asp-dAMP analogue. However, a
modelling study (data not shown) demonstrates that Glu-
dAMP can also be accommodated in the active site of the
enzyme complex. Apparently, the binding of Glu-dAMP
is not optimal to function as substrate in the polymeriza-
tion reaction. It can also lead to misalignment of the
negative charge in the polymerase active site and disrup-
tion of the binding of the catalytic metal ions. HIV RT
and Therminator DNA pol were eﬀective in incorporation
of His-dAMP suggesting that imidazole moiety of the
histidine side chain might likewise be involved in binding
interactions of metal ions and the triphosphate group.
Interestingly, a modelling study demonstrates that His-
dAMP is bound in a diﬀerent way as Asp-dAMP and that
the a-carboxylate group is involved in interactions with
Lys-65 and Arg-72, while the imidazole ring of His-dAMP
is involved in cation-p interactions.
Moreover, very little or no nucleotide incorporation
occurred when phosphoramidate nucleotides coupled to
non-polar amino acids were used as substrates for HIV
RT or DNA polymerase. These observations provide
further support for the rationale that the electrostatic
interactions are indispensable for polymerase recognition,
the assembly of the catalytic complex in the active site and
for chain elongation. These suggestions, however, need
to be conﬁrmed by co-crystallization experiments and
molecular dynamics.
In conclusion, aspartyl phosphoramidate moiety serves
as a mimic of a pyrophosphate group and behaves as a
good leaving group in a nucleotidyl transfer reaction.
Incorporation of nucleotides, although to a lesser extent,
was likewise observed for histidyl and glycinyl phosphor-
amidates, respectively. The fact that diﬀerent AA-dAMP
function as substrate for the polymerase reaction, does not
mean that they bind to the enzyme in the same way and
that their mode of action is identical.
Therefore, is seems feasible to use chain terminating
nucleotide analogues coupled to newly designed leaving
groups through a phosphoramidite or phosphodiester
linkage for a direct inhibition of HIV-RT or other viral
polymerase. Another application may be the enzymatic
synthesis of DNA containing natural and unnatural
nucleobases, avoiding at times cumbersome nucleoside
triphosphate synthesis and puriﬁcation. As we emphasized
elsewhere (45), the propagation of certain genes and
replicons that would require the exogenous supply of
nucleic acid precursors absent from cells and natural food
chains, such as deoxynucleotide-aspartate conjugates,
stands as a promising option for preventing genetic
pollution by nutritionally containing the dissemination
of genetically engineered microbes. The logical next
step toward implementing dNAPs, e.g. the set of
deoxynucleotide-aspartate conjugates corresponding to
the four bases A, C, G and T, as bona ﬁde precursors of
certain DNA plasmids in a bacterial cell will be to evolve a
DNA polymerase variant with an enhanced eﬃciency and
selectivity in condensing these substrates but having lost
the capability to condense canonical dNTPs. Techniques
of computational design (46) and of in vitro evolution (47)
could be applied for accomplishing such a swap of
substrate speciﬁcity in the active site of HIV reverse
transcriptase and other DNA polymerases.
MATERIALS AND METHODS
Synthesis
The synthesis and analysis of all L-AA-dAMP compounds
have been described in the Supplementary Data of the ﬁrst
communication of this research (7).
D-Asp-dAMP. 20-Deoxyadenosine 50-monophosphate
(100mg, 0.30mmol) and D-aspartic acid methyl ester
(418mg, 2.11mmol) were dissolved in
tBuOH (2.7ml) and
water (0.94ml). Then, a solution of DCC (312mg,
1.51mmol) in
tBuOH (2ml) was added and the reaction
mixture was heated in a boiling water bath for 4h. The
residue was resuspended in water (20ml) and extracted
with diethyl ether (4 15ml). The aqueous phase was then
lyophilized. The colourless solid that was obtained
was subjected to column chromatography on silica
gel using the following solvent gradient: CHCl3:MeOH
(5:1), CHCl3:MeOH:H2O (5:2:0.25), CHCl3:MeOH:H2O
(5:3:0.5) and ﬁnally CHCl3:MeOH:H2O (5:4:1). The
product obtained was treated with 2ml of 0.4M NaOH
Figure 14. Model of L-His-dAMP bound in the active site of RT.
Stabilization of the structure is maintained by hydrogen bonding/ionic
bonds (indicated by dotted lines) and a potential cation-p interaction
between the neutral histidine group of L-His-dAMP and one of
the Mg
2+ ions. The distance of this Mg
2+ to the plane of that histidine
is 4.4A ˚ .
Nucleic Acids Research, 2007, Vol. 35, No. 15 5069in MeOH–H2O (1:1) and the reaction mixture was allowed
to stir at room temperature for 4h. The solvents were then
removed under reduced pressure. The white solid that was
obtained was subjected to column chromatography on
silica gel using the following solvent gradient:
iPrOH,
iPrOH:NH3:H2O (7:1:1). The product was isolated as a
colourless solid (94mg, 70% for two steps).
1H NMR
(300MHz, D2O) d 8.41 (1H, s), 8.12 (1H, s), 6.41 (1H, m),
4.71 (1H, m), 4.24 (1H, m), 3.95–3.89 (2H, m), 3.77 (1H,
m), 2.41–2.84 (4H, m).
13C NMR (75MHz, D2O) d 177.5,
174.3, 155.1, 152.3, 148.4, 139.8, 118.3, 85.9 (d, J=9.0),
83.5, 71.1, 64.0 (d, J=5.2), 43.1, 38.9, 36.5.
31P NMR
(121MHz, D2O) d 6.85. HRMS calcd for C14H18N6O9P
(M-H
+) 445.08729, found 445.08755.
L-Asp-PMEA. PMEA (50mg, 0.18mmol) was coupled
with L-aspartic acid methyl ester (253mg, 1.28mmol)
in the presence of DCC (189mg, 0.92mmol) and
tBuOH (2.8ml)–H2O (0.57ml) as described above for
D-Asp-dAMP. After puriﬁcation by column chromato-
graphy, the white solid obtained was treated with 0.4M
NaOH in MeOH–H2O as described for D-Asp-dAMP.
The product was isolated as a colourless solid (44mg, 58%
for two steps).
1H-NMR (D2O): d 8.17 (2H, bs), 4.40–4.38
(2H, m), 4.93–4.88 (3H, m), 3.58–3.56 (2H, m), 2.81 (1H,
dd, J=3.9, J=17.5), 2.69 (1H, dd, J=8.2, J=17.5).
13C NMR (75MHz, D2O) d 177.5, 174.2, 154.9, 151.8,
148.5, 142.8, 117.9, 70.2 (d, J=11.1), 68.1, 52.2, 43.1,
36.5.
31P NMR (121MHz, D2O) d 15.5. HRMS calcd for
C12H16N6O7P (M-H
+) 387.08181, found 387.10119.
Polymerase assay
The assays for single nucleotide incorporation by HIV
reverse transcriptase and the steady state kinetics has been
described (7).
In the case of Therminator DNA polymerase, the
enzyme was obtained from Westburg (NEB) (2U/ml) and
the reactions were carried out in a 10X Thermopol
reaction buﬀer containing 20mM TRIS-HCl, 10mM
KCl, 2mM MgSO4, 0.1% Triton X-100, pH 8.8. The
ﬁnal concentration of the Therminator DNA pol in the
reaction mixture was 8.33 10
 4U/ml. The polymerase
reaction involving Therminator DNA polymerase or any
other thermostable polymerase [Vent (exo
 ), Taq DNA
polymerase] was carried out in a similar way as the HIV
RT reaction with some modiﬁcations. The dNTP solu-
tions and the primer/template/DNA polymerase mixture
solutions were topped with mineral oil (30–60ml) and pre-
incubated at 708C for 2min. The polymerase reactions
were performed at 708C as well.
Molecular modelling
Electrostatic charges. Atomic electrostatic charges of the
L-Asp-dAMP and L-His-dAMP molecules, to be used in
the amber software package were calculated from the
electrostatic potential at the 6-31G
  level using the
package Gamess (48) and the two-stage RESP ﬁtting
procedure (49) L-Asp-dAMP is supposed to carry an
electric charge of  3 while L-His-dAMP is supposed to
have a charge of  2.
Amber parameters. The force ﬁeld parameters used in the
amber simulations are those from the parm99 dataset (50).
Missing bond and angle parameters were taken from
comparable bonds, or angles from the AMBER force
ﬁeld. In particular, the parameters for the P-N bond were
added.
Model building. The modelling is based on the crystal
structure of RT in complex with a trapped entering
triphosphate (pdb structure ﬁle 1RTD) (51). The geometry
of the L-Asp-dAMP and L-His-dAMP molecules was
optimized in gamess in the AM1 force ﬁeld (48). A locally
developed software was used to ﬁt the L-Asp-dAMP
structure on the entering triphosphate TTP in the 1RTD
structure. This method uses ﬂexible superposition by
changing dihedral angles and optimizing the atomic
overlap. In this 7 modelling work, the variable angles
were the  angle and the angles in the P-bound leaving
group. The base was modiﬁed to an adenine and the
complementary adenine base (E5) was changed into a
thymine by an inverse ﬁtting procedure using Quatﬁt
(Quatﬁt program in CCL software archives). The same
procedure was repeated for the L-His-dAMP molecule.
Molecular dynamics simulations. Solvated molecular
dynamics was used to verify the stability (52). The
complex was solvated in a truncated octahedron TIP3P
water box (53). 31 Na
+ counter-ions were then added to
get an electrostatic neutral system. The water molecules
and counter-ions were then allowed to relax their positions
while keeping the solute ﬁxed. Molecular dynamics
simulations were then initiated with all restraints removed,
with periodic boundary conditions and using a cutoﬀ
distance of 8A ˚ for the non-bonded interactions and the
particle-mesh-Ewald method for the summation of the
coulombic interactions (54), MD time step=0.002ps.
Initially, for 20ps, the system was heated up to 300K with
constant-T, constant-V conditions while restraining the
position of the solute and using a Langevin temperature
equilibration scheme. The MD was then continued for
200ps at constant T and constant P. The simulation
temperature was 300K. The presence of the base pair
hydrogen bonds between primer and template strand was
taken as a valid indicator for the stability of the structures:
nearly all H-bonds were still present in the ﬁnal dynamic
structures. An average structure of the last 50ps was
generated and analysed.
NMR Spectroscopy
NMR Spectra were recorded on a Bruker Avance II 500
NMR spectrometer. Chemical shifts d are indicated in
ppm relative to the solvent signals (1H and 13C) or H3PO4
as external standard (
31P).
The
31P resonance of L-Asp-dAMP could be observed at
6.90p.p.m. and the assignment was conﬁrmed using an
1H detected
31P-
1H COSY in which a clear scalar coupling
could be observed between the
31P resonance and
the a-proton of the L-Asp moiety and between the
31P resonance and the 50 protons of the deoxyribose
moiety.
5070 Nucleic Acids Research, 2007, Vol. 35, No. 15Degradation of L-Asp-dAMP was monitored at pH 8.8
and pH 7 using the integral of the compound’s 31P
resonance peak. After each period of 45min at 708C
the sample was cooled to 258C and a
31P spectrum was
recorded. The degradation could be ﬁtted to Equation (1),
which indicates that the degradation follows a ﬁrst order
kinetics. C represents the integral of the
31P resonance
signal after one or several periods of 45min at 708C. C0 is
the integral of the
31P resonance signal at the start of the
degradation and was set to 100.
LnðCÞ¼LnðC0Þ kt 1
Plotting the natural logarithm of the integrals against time
allowed us to extract the degradation constant and half-
life at both pH conditions (Figure 15).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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